Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol in African Americans With Resistant Hypertension
NCT05888233Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in resistant hypertension (RH), sponsored by VA Office of Research & Development. Started Sep 2024; status: completed.
02
Drugs
allopurinol
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT05888233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05888233.